Investment Analysts’ Updated EPS Estimates for January, 17th (ABBN, AIR, BMW, DAI, FBP, FELE, FNF, FSB, GECFF, GEMP)

Investment Analysts’ updated eps estimates for Wednesday, January 17th:

ABB (VTX:ABBN) was given a CHF 30 target price by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

ABB (VTX:ABBN) was given a CHF 25 target price by analysts at Berenberg Bank. The firm currently has a neutral rating on the stock.

Airbus (EPA:AIR) was given a €90.00 ($107.14) target price by analysts at Kepler Capital Markets. The firm currently has a neutral rating on the stock.

Bayerische Motoren Werke (ETR:BMW) was given a €81.00 ($96.43) price target by analysts at Morgan Stanley. The firm currently has a sell rating on the stock.

Daimler (ETR:DAI) had its neutral rating reissued by analysts at Barclays PLC.

First Bancorp (NYSE:FBP) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “First Bancorp distinguished itself by providing innovative marketing strategies and novel products to attract clients. Besides the branches and lending offices, the Corporation has offered a telephone information service called Telebanco since 1983. This was the first telebanking service offered in Puerto Rico. The Corporation’s clients have access to an extensive ATM network all over the world. The Corporation was the first in Puerto Rico to open on weekends and the first to offer in-store branches to its clients. “

Franklin Electric (NASDAQ:FELE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Franklin Electric is a global leader in the production and marketing of systems and components for the movement of water and automotive fuels. Franklin Electric has produced high-quality industrial pumps, filters and accessories. By introducing the new Little Giant PondWorks program, Franklin Electric now brings the same exceptional knowledge, experience, and quality to the recreational water gardening and outdoor living markets. “

FNF Group of Fidelity National Financial (NYSE:FNF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Fidelity National Title Group, Inc. is a leading provider of title insurance, specialty insurance and claims management services. FNT is one of the nation’s largest title insurance companies through its title insurance underwriters. FNT also provides flood insurance, personal lines insurance and home warranty insurance through it specialty insurance business. FNT also is a leading provider of outsourced claims management services to large corporate and public sector entities through its minority-owned subsidiary, Sedgwick CMS. “

Franklin Financial Network (NYSE:FSB) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Franklin Financial Network, Inc. is a bank holding company for Franklin Synergy Bank. The Company provides banking and financial services to small businesses, corporate entities, local Governments and individuals. It offers demand, savings, checking, NOW deposit accounts, certificates of deposit, money market deposit accounts, commercial and residential construction, commercial and installment loans, lines secured by home equity and mortgage loans as well as compliance consulting services. The company operates primarily in Brentwood, Spring Hill and the Cool Springs; the Westhaven and Berry Farms communities of Franklin, Tennessee. Franklin Financial Network, Inc. is headquartered in Franklin, Tennessee. “

GECINA (OTCMKTS:GECFF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Gecina SA is a real estate investment trust primarily in France. It owns, manages, develops and leases out offices, residential assets and student residences. Gecina SA is headquartered in Paris, France. “

Gemphire Therapeutics (NASDAQ:GEMP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company’s product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies. Gemphire Therapeutics Inc. is headquartered in Northville, Michigan. “

CGI Group (NYSE:GIB) (TSE:GIB.A) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CGI provides the full range of IT services including consulting, systems integration and the management of business and IT functions. The company’s primary focus is large scale systems integration and outsourcing contracts. “

GlycoMimetics (NASDAQ:GLYC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States. “

Global Medical REIT (NYSE:GMRE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

Rio Tinto (LON:RIO) was given a GBX 4,200 ($56.96) price target by analysts at S&P Global. The firm currently has a neutral rating on the stock.

William Hill (LON:WMH) was downgraded by analysts at Peel Hunt to a reduce rating. Peel Hunt currently has GBX 290 ($3.93) price target on the stock.

Zurich Insurance Group (VTX:ZURN) was given a CHF 317 target price by analysts at JPMorgan Chase & Co.. The firm currently has a neutral rating on the stock.

Receive News & Ratings for ABB Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABB Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit